Aryl hydrocarbon receptor (ahr) agonists and uses thereof

A compound of Formula (I):

• or a pharmaceutically acceptable salt thereof, wherein:
• Ring A is an optionally substituted 5-membered heteroaromatic ring having 1-3 heteroatoms independently selected from N, O, or S;
• Ring B is an optionally substituted ring selected from phenyl, a 6-membered heteroaromatic ring having 1-3 N, a 8-10 membered bicyclic aromatic ring, and a 8-10 membered bicyclic heteroaromatic ring having 1-5 heteroatoms independently selected from N, O, or S;
• Ring C is optionally substituted phenyl or 6-membered heteroaromatic ring having 1-3 N;
• R11 is —R, —C(O)—RW, —C(═NRW)—RW, —S(O)2—RW, or —S(O)—RW;
• RW is —R, —N(R)2, —NR—OR, —N(R)—N(R)2, —N(OR)—N(R)2, —N(R)—N(OR)R, —OR, —O—N(R)2, or —SR;
• and
• R is hydrogen, optionally substituted C1-6 aliphatic, an optionally substituted 3-7 membered carbocyclic ring, or an optionally substituted 3-7 membered heterocyclic ring having 1-3 heteroatoms independently selected from N, O, or S, or two R's together with the nitrogen to which they attach form an optionally substituted 5-7 membered heterocyclic ring having 0-2 heteroatoms independently selected from N, O, or S in addition to the nitrogen to which the two R's attach,
• provided that the compound is not